|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07C 231/02 | |
| C07C 231/14 | |||
| C07C 231/24 | |||
| C07C 237/46 |
| (11) | Number of the document | 2900632 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13771008.3 |
| Date of filing the European patent application | 2013-09-17 | |
| (97) | Date of publication of the European application | 2015-08-05 |
| (45) | Date of publication and mention of the grant of the patent | 2019-10-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/060081 |
| Date | 2013-09-17 |
| (87) | Number | WO 2014/052091 |
| Date | 2014-04-03 |
| (30) | Number | Date | Country code |
| 20121102 | 2012-09-27 | NO |
| (72) |
THANING, Mikkel, NO
OLSSON, Andreas, NO
GLOGARD, Christian, NO
|
| (73) |
GE HEALTHCARE AS,
Nycoveien 1, 0485 Oslo,
NO
|
| (54) | PREPARATION OF AN INTERMEDIATE COMPOUND OF IOFORMINOL |
| PREPARATION OF AN INTERMEDIATE COMPOUND OF IOFORMINOL |